48 reports

Drugs For Respiratory Diseases P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A

  • Cancer Hormonal Therapy
  • Respiratory Disease
  • Market Size
  • Novartis AG
  • Pfizer Inc.

ANTIVIRALS ARE GIVEN TO HIGH-EXACERBATION-RISK INDIVIDUALS WHO ARE OVER ## YEARS OLD DURING THE FLU EPIDEMIC SEASON TO FURTHER PREVENT EXACERBATION AND TO IMPROVE QOL.

  • Cancer Hormonal Therapy
  • Respiratory Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Sunovion Pharmaceuticals Inc.
  • Vendor landscape

It also signed a deal worth $## billion with Moderna Therapeutics for its messenger RNA therapeutics platform in developing new antiviral vaccines and passive immunity therapies.

  • Respiratory Disease
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG

Cough and cold held a nominal share of ##%.

  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Novartis AG
  • Product News

Part ## of the trial generated good safety data and additionally demonstrated that SNG## significantly elevates antiviral biomarkers in the lungs of COPD patients.

  • Healthcare
  • Pharmaceutical
  • Respiratory Disease
  • United Kingdom
  • Synairgen plc

Similarly, the Universities' portfolio in Preclinical and Discovery stages comprises ## and ## molecules, respectively.

  • Cough And Cold
  • Respiratory Disease
  • United States
  • Company Operations
  • Product Initiative

The molecules developed by Companies in Filing rejected/ Withdrawn, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Cough And Cold
  • Pharmaceutical
  • Respiratory Disease
  • United States
  • Product Initiative

Increased environmental pollution Expected launch of personalized medicine High prevalence of asthma Promising late-stage pipeline molecules Expected launch of personalized medicine Increased environmental pollution Low Low ## ## ## ## ## High High ## ## ## ## ## ## ## ## ## ##

  • Respiratory Disease
  • United States
  • AstraZeneca PLC
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc

The current products for IPF have generated global revenues in excess of $## billion in 2016.

  • Pharmaceutical
  • Respiratory Disease
  • Australia
  • United States
  • Pharmaxis Ltd

The prominent features of this report are - ##.

  • Cancer Hormonal Therapy
  • Clinical Trial
  • Respiratory Disease
  • World
  • Product Initiative

Mecasermin supplies recombinant-DNA-origin IGF-##, which binds to the Type I IGF-## receptor.

  • Pharmaceutical
  • Respiratory Disease
  • Therapy
  • United States
  • Product Initiative
  • ANTIBODY TO INHIBIT IL-33 FOR ASTHMA - DRUG PROFILE
  • ASTHMA - PIPELINE BY ZAI LAB LTD, H2 2018

The company offers API' s and intermediates for antibiotic, antiviral, antifungal, anti-inflammatory, anti-diabetic, anti-HIV, anti-HCV, betalactase inhibitors, PEGlyated compounds and anti-histamines.

  • Asthma
  • Cancer Hormonal Therapy
  • Respiratory Disease
  • United States
  • AstraZeneca PLC

Mecasermin supplies recombinant-DNA-origin IGF-##, which binds to the Type I IGF-## receptor.

  • Clinical Trial
  • Respiratory Disease
  • Therapy
  • United States
  • Product Initiative

Mirrored commercial units - one for BioPharmaceuticals and one for Oncology.

  • Cancer Hormonal Therapy
  • Respiratory Disease
  • United States
  • Company
  • Vectura Group plc
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Pharmaceutical
  • Respiratory Disease
  • World
  • Product Initiative
  • Novartis AG

The prominent features of this report are - ##.

  • Cancer Hormonal Therapy
  • Respiratory Disease
  • Therapy
  • World
  • Pfizer Inc.

The prominent features of this report are - ##.

  • Cancer Hormonal Therapy
  • Clinical Trial
  • Drug Development
  • World
  • Product Initiative

OKG-## is a topical ophthalmic formulation of ranpirnase, a ribonuclease (RNase) that contains broad-spectrum antiviral properties.

  • Cancer Hormonal Therapy
  • Eye Disease
  • Respiratory Disease
  • World
  • Product Initiative
  • Clinical Trial profile. 264 Trial Title
  • 5. All the trials included are unique trials.

Boehringer Sohn AG & Co KG ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Teva Pharmaceutical Industries Ltd ## ## ## ## ## ## ## ## Abbott Laboratories ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Bayer AG Aurobindo Pharma Ltd AstraZeneca Plc ## ## ##

  • Cancer Hormonal Therapy
  • Chronic Disease
  • Respiratory Disease
  • China
  • World

It offers products in the therapeutic areas of oncology, hematology, immune diseases, antibiotics, antivirals, neurology, cardiology, multiple sclerosis, hemophilia and diabetes, among others.

  • Cancer Hormonal Therapy
  • Endocrine Disease
  • Respiratory Disease
  • United States
  • Alnylam Pharmaceuticals, Inc.

It offers products in the therapeutic areas of oncology, hematology, immune diseases, antibiotics, antivirals, neurology, cardiology, multiple sclerosis, hemophilia and diabetes, among others.

  • Cancer Hormonal Therapy
  • Endocrine Disease
  • Monoclonal Antibody
  • Respiratory Disease
  • Alnylam Pharmaceuticals, Inc.
  • Research and Development Brief
  • ASTHMA - PIPELINE BY LONGEVITY BIOTECH INC, H1 2018

Its products line is at preclinical stage and focuses on cardiovascular, antiviral, neuroscience, metabolic and oncological areas.

  • Asthma
  • Cancer Hormonal Therapy
  • Research And Development
  • Respiratory Disease
  • AstraZeneca PLC
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

## ## India ## ## ## ## ## ## ## ## Russia ## ## ## ## ## ## ## ## Brazil ## ## ## ## ## ## ## ## Mexico ## ## ## ## ## ## ## ## Indonesia ## ## ## ## ## ## ## ## Turkey Source: GlobalData' s Pharma Intelligence Center Clinical Tr

  • Cancer Hormonal Therapy
  • Clinical Trial
  • Pharmaceutical
  • Respiratory Disease
  • World

The trial will be a randomized (##:##), placebo-controlled, double-blind study.

  • Cancer
  • Cancer Hormonal Therapy
  • Respiratory Disease
  • World
  • Pfizer Inc.
  • Official Title
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Ansun BioPharma announced that the Division of Antiviral Products of the U. S.

  • Cancer Hormonal Therapy
  • Respiratory Disease
  • Therapy
  • World
  • Product Initiative

Antiviral responses in HCV- and HBV-infected patients have been observed as measured by declines in HCV RNA and quantitative HBV surface antigen.

  • Blood Disease
  • Cancer
  • Cancer Hormonal Therapy
  • Respiratory Disease
  • Bristol-Myers Squibb Company

Exportin ## (Chromosome Region Maintenance ## Protein Homolog or XPO##) - Overview EXPORTIN ## (XPO##) OR CHROMOSOMAL MAINTENANCE ## (CRM##) IS A EUKARYOTIC PROTEIN.

  • Cancer
  • Cancer Hormonal Therapy
  • United States
  • Product Initiative
  • Karyopharm Therapeutics Inc.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Reddy' s Laboratories Ltd ## ## ## ## ## Merck & Co Inc ## ## ## ## ## Johnson & Johnson ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## ## Bayer AG ## ## ## ## ## Pfizer Inc ## ## ## ## ## Novartis AG ## ## ## ## ## Lotus Labs Pvt Ltd ## ## ## ## ## C.

  • Clinical Trial
  • Cough And Cold
  • Respiratory Disease
  • World
  • Dr. Reddy's Laboratories Limited

The changes took effect on ## October 2018 and ## January 2019.

  • Asthma
  • Cancer Hormonal Therapy
  • Clinical Trial
  • Respiratory Disease
  • Novartis AG
  • KR-22809 - DRUG PROFILE

The antiviral biomarker analysis has been completed and revealed that COPD patients inhaling SNG## had significantly increased markers of antiviral activity.

  • Cancer Hormonal Therapy
  • Chronic Disease
  • Respiratory Disease
  • United States
  • AstraZeneca PLC